Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Gastro-entero-pancreatic neuroendocrine tumors (GEP-NET) are a heterogeneous tumor entity with respect to biological behaviour and prognosis. This makes diagnosis and treatment a major challenge.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Siebenhüner A
Authors: Duschek S, Weber A, Curioni-Fontecedro A, Siebenhüner A,
Keywords: Biomarker, immunohistochemistry, GEP-NET, TMA, Prognosis, hormone receptor,
Introduction: Sunitinib (Sun) and Everolimus (Eve) are effective treatments for advanced GEP-NET. Lack of standard treatment sequencing and potential toxicities may preclude it´s use.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Pérez de la Puente C
Authors: Pérez de la Puente C, Mando P, Rizzo M, Rivero S, Pesce V,
Keywords: TNE, therapy target,
#610 Effectiveness of PRRT for NETs in Germany: An Analysis of 450 Patients
Introduction: Peptide receptor radionuclide therapy targets somatostatin receptors expressed on well-differentiated neuroendocrine neoplasms. Retrospective monocentric studies indicate that peptide receptor radionuclide therapy is an effective treatment for patients with neuroendocrine neoplasms.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Hörsch D
Authors: Hörsch D, Ezziddin S, Haug A, Gratz K, Dunkelmann S,
Keywords: PRRT,
Introduction: Expression of somatostatin receptors (SSTRs) and dopamine 2 receptor (D2R) in neuroendocrine tumors is of clinical importance, as somatostatin analogues and dopamine agonists are used in biotherapy.
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Kanakis G, Grimelius L, Trigidou R, Kaltsas G, Tsolakis A,
Keywords: somatostatin receptor subtypes, dopamine receptor 2, lung carcinoids,